Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander M M Eggermont

Showing results (1-10 of 335) with videos related to

Pageof 34
Sort By:
Bulletin Du Cancer|October 16, 2019
The impact of the immunotherapy revolution on lymph nodal surgeryAlexander M M Eggermont
Annals of Surgical Oncology|April 14, 2005
Reducing the need for sentinel node procedures by ultrasound examination of regional lymph nodesAlexander M M Eggermont
Expert Review of Anticancer Therapy|October 18, 2002
Critical appraisal of IFN-alpha-based adjuvant therapy in stage II-III malignant melanomaAlexander M M Eggermont
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Therapeutic cancer vaccine development: will it ride the wave of new immunomodulatory agents?Alexander M M Eggermont
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2006
Reaching first base in the treatment of metastatic melanomaAlexander M M Eggermont
Surgical Oncology Clinics of North America|April 25, 2006
Randomized trials in melanoma: an updateAlexander M M Eggermont
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Adjuvant therapy for high-risk melanomaAlexander M M Eggermont
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
Current status of interferon-alpha in the treatment of melanomaAlexander M M Eggermont
Nature Reviews. Clinical Oncology|April 25, 2009
Immunotherapy: Vaccine trials in melanoma -- time for reflectionAlexander M M Eggermont
Current Opinion in Oncology|March 7, 2002
European approach to the treatment of malignant melanomaAlexander M M Eggermont
Pageof 34

Showing results (1-10 of 335) with videos related to

Sort By:
Pageof 34
Bulletin Du Cancer|October 16, 2019
The impact of the immunotherapy revolution on lymph nodal surgeryAlexander M M Eggermont
Annals of Surgical Oncology|April 14, 2005
Reducing the need for sentinel node procedures by ultrasound examination of regional lymph nodesAlexander M M Eggermont
Expert Review of Anticancer Therapy|October 18, 2002
Critical appraisal of IFN-alpha-based adjuvant therapy in stage II-III malignant melanomaAlexander M M Eggermont
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Therapeutic cancer vaccine development: will it ride the wave of new immunomodulatory agents?Alexander M M Eggermont
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2006
Reaching first base in the treatment of metastatic melanomaAlexander M M Eggermont
Surgical Oncology Clinics of North America|April 25, 2006
Randomized trials in melanoma: an updateAlexander M M Eggermont
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Adjuvant therapy for high-risk melanomaAlexander M M Eggermont
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
Current status of interferon-alpha in the treatment of melanomaAlexander M M Eggermont
Nature Reviews. Clinical Oncology|April 25, 2009
Immunotherapy: Vaccine trials in melanoma -- time for reflectionAlexander M M Eggermont
Current Opinion in Oncology|March 7, 2002
European approach to the treatment of malignant melanomaAlexander M M Eggermont
Pageof 34